The influence of DHEA pretreatment on prepulse inhibition and the HPA-axis stress response in rat offspring exposed prenatally to polyriboinosinic-polyribocytidylic-acid (PIC)

Neuroscience Letters

Volumn 521, Issue 1, 2012, Pages 6-10

  Maayan, Rachel ^a   Ram, Edward ^a   Biton, Doron ^a   Cohen, Hagit ^b   Baharav, Ehud ^a   Strous, Rael D ^a   Weizman, Abraham ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Corticosterone; Dehydroepiandrosterone (DHEA); Prenatal infection; Schizophrenia

Indexed keywords

CORTICOSTERONE; POLYINOSINIC POLYCYTIDYLIC ACID; PRASTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY RESPONSE; BRAIN TISSUE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEWBORN; NONHUMAN; PRENATAL EXPOSURE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROGENY; RAT; SCHIZOPHRENIA; STARTLE REFLEX; STRESS;

ACOUSTIC STIMULATION; ANIMALS; CORTICOSTERONE; DEHYDROEPIANDROSTERONE; FEMALE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; POLYNUCLEOTIDES; PREFRONTAL CORTEX; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; RNA VIRUS INFECTIONS; SCHIZOPHRENIA; SEX FACTORS; STARTLE REACTION; STRESS, PHYSIOLOGICAL;

EID: 84862610039     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.05.034     Document Type: Article

References (32)

1. Bayer S.A., Altman J. Development of the endopiriform nucleus and the claustrum in the rat brain. Neuroscience 1991, 45:391-412.
2. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophrenia Bulletin 2006, 32:200-202.
3. Brown A.S., Derkits I.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. American Journal of Psychiatry 2010, 167:261-280.
4. Charych E.I., Liu F., Moss S.J., Brandon N.J. GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders. Neuropharmacology 2009, 57:481-495.
5. Dafny N., Yang P.B. Interferon and the central nervous system. European Journal of Pharmacology 2005, 523:1-15.
6. Dillon J.S. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Current Drug Targets. Inflammation and Allergy 2005, 4:377-385.
7. Fortier M.-E., Luheshi G.N., Boksa P. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of infectious agent and the stage of pregnancy. Behavioural Brain Research 2007, 181:270-277.
8. Gilmore J.H., Jarskog L.F., Vadlamudi S. Maternal poly I:C exposure during pregnancy regulation TNF alpha BDNF and NGF expression in neonatal brain and the maternal-fetal unit of the rat. Journal of Neuroimmunology 2005, 159:106-112.
9. Golubchik P., Lewis M., Maayan R., Sever J., Strous R., Weizman A. Neurosteroids in child and adolescent psychopathology. European Neuropsychopharmacology 2007, 17:157-164.
10. Lazaridis I., Charalampopoulos I., Alexaki V.I., Avlonitis N., Pediaditakis I., Efstathopoulos P., Calogeropoulou T., Castanas E., Gravanis A. Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis. PLoS Biology 2011, 4:e1001051.
11. Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annual Review of Neuroscience 2002, 25:409-432.
12. Maayan R., Touati-Werner D., Ram E., Strous R., Keren O., Weizman A. The protective effect of frontal-cortex dehydroepiandrosterone in anxiety and depressive models in mice. Pharmacology Biochemistry and Behavior 2006, 85:415-421.
13. Meyer U., Feldon J., Schedlowski M., Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neuroscience and Biobehavioral Reviews 2005, 29:913-947.
14. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., Yee B.K., Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. Journal of Neuroscience 2006, 26:4752-4762.
15. Nachshoni T., Ebert T., Abramovitch Y., Assael-Amir M., Kotler M., Maayan R., Weizman A., Strous R.D. Improvement of extrapyramidal symptoms following dehydroepiandrosterone (DHEA) administration in antipsychotic treated schizophrenia patients: a randomized, double-blind placebo controlled trial. Schizophrenia Research 2005, 79:251-256.
16. Nyffeler M., Meyer U., Yee B.K., Feldon J., Knuesel I. Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implication for schizophrenia. Neuroscience 2006, 143:51-62.
17. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biological Psychiatry 2006, 59:546-554.
18. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB Journal 1992, 6:2311-2322.
19. Ritsner M., Maayan R., Gibel A., Weizman A. Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenics and healthy subjects. European Neuropsychopharmacology 2007, 17:358-365.
20. Shirayama Y., Muneoka K.T., Iwata M., Ishida H., Hazama G., Kawahara R. Pregnenolone and dehydroepiandrosterone administration in neonatal rats alters the immunoreactivity of hippocampal synapsin I, neuropeptide Y and glial fibrillary acidic protein at post-puberty. Neuroscience 2005, 133:147-157.
21. Spivak B., Maayan R., Kotler M., Mester R., Gil-Ad I., Shtaif B., Weizman A. Elevated circulating level of GABA-antagonistic neurosteroids in patients with Combat Related Posttraumatic Stress Disorder. Psychological Medicine 2000, 30:1227-1231.
22. Strous R.D., Spivak B., Yoran-Hegesh R., Maayan R., Averbuch E., Kotler M., Mester R., Weizman A. Analysis of neurosteroid level in Attention Deficit Hyperactivity Disorder. International Journal of Neuropsychopharmacology 2001, 4:259-264.
23. Strous R.D., Maayan R., Lapidus R., Stryjer R., Lustig M., Kotler M., Weizman A. Dehydroepiandrosterone (DHEA) augmentation in the management of negative, depressive and anxiety symptoms in schizophrenia. Archives of General Psychiatry 2003, 60:133-141.
24. Strous R.D., Maayan R., Lapidus R., Goredetsky L., Zeldich E., Kotler M., Weizman A. Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulfate in first-episode schizophrenia: relationship to gender, aggression and symptomatology. Schizophrenia Research 2004, 71:427-434.
25. Strous R.D., Maayan R., Weizman A. The relevance of neurosteroids to clinical psychiatry: from laboratory to bedside. European Neuropsychopharmacology 2006, 16:155-169.
26. Suzuki M., Wright L.S., Marwah P., Lardy H.A., Svendsen N. Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cells cultures derived from the fetal cortex. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:3202-3207.
27. Tohmi M., Tsuda, Watanabe Y., Kakita A., Nawa H. Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin. Neuroscience Research 2004, 50:67-75.
28. Vaitl D., Lipp O., Bauer U., Schüler G., Stark R., Zimmermann M., Kirsch P. Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses. Schizophrenia Research 2002, 55:147-158.
29. Van den Buuse M., Garner B., Gogos A., Kusljic S. Importance of animal models in schizophrenia research. Australian and New Zealand Journal of Psychiatry 2005, 39:550-557.
30. Zuckerman L., Weiner I. Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation. Psychopharmacology 2003, 169:308-313.
31. Zuckerman L., Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. Psychiatry Research 2005, 39:311-323.
32. Zuckerman L., Rehavi M., Nachman R., Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Journal of Neuropsychopharmacology 2003, 28:1778-1789.